Delivery Order SPE2DB20D3103-SPE2DB24FP2B8
- Not listed
- This federal contract award, valued at $3,998.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall XR 20 mg capsules, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,635.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Adderall XR 10 mg capsules, a medication commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Delivery Order, with a Firm Fixed Price pricing type and a completion date of February 9, 2023. It is not designated as a set-aside contract, indicating open...
- This federal contract award, valued at $3,681.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall XR 30 mg capsules, a specialty medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,155.40, is for the delivery of 4,559,929,302 units of Adderall XR 10 mg capsules, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
- This federal contract award, valued at $4,588.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall XR 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
- This federal contract award, valued at $2,124.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Adderall XR 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
- This federal contract award, valued at $4,991.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Adderall XR 15 mg capsules, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing type and an ultimate completion date of February 3, 2025. It is not designated as a...
- This federal contract award, valued at $1,180.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Adderall XR 10 mg capsules, a prescription drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. There is no set-aside...
- This federal contract award, valued at $2,127.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The contract is for the delivery of Adderall XR 10 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD)....
- This federal contract award, valued at $2,720.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FU8ZA) for the supply of Adderall XR 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 18, 2025 and is a firm fixed-price arrangement. This award is not designated as a set-aside contract,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FP2B8Delivery Order
This federal contract award, valued at $1,827.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADDERALL XR 10 MG capsules in 100-count packages, a prescription medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/17/24 |